KevinAnthonyGrimesMDMPH, FACP, FIDSA
Infectious Disease • Houston, TXHIV/AIDS Medicine, Transplant/Immunocompromised States, Mycobacterial Disease
Deputy Chair of Medicine, Assistant Professor of Clinical Medicine Weill Cornell Medical College
Dr. Grimes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Ste 1540
Houston, TX 77030Phone+1 713-799-9997Fax+1 713-799-2511
Summary
- Dr. Kevin Grimes is an infectious disease specialist in Houston, TX and is affiliated with multiple hospitals in the area, including Kindred Hospital Houston Medical Center and Houston Methodist Hospital. He received his medical degree from University of Texas Medical School and has been in practice 15 years. He is experienced in transplant infectious diseases, CMV, fungal, nocardia, and mycobacterial and nosocomial infections and antibiotic stewardship.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2005 - 2007- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2002 - 2005
McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
TX State Medical License 2006 - 2025- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 24 citationsEfficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients.Julius Balogh, Sherilyn Gordon Burroughs, Maha Boktour, Samir J. Patel, Ashish Saharia
Liver Transplantation. 2016-02-01 - 97 citationsEfficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phas...Andre C. Kalil, Aneesh K. Mehta, Thomas F Patterson, Nathaniel B. Erdmann, Carlos A. Gomez
The Lancet. Respiratory Medicine. 2021-10-18 - 61 citationsBaricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.Cameron R Wolfe, Kay M Tomashek, Thomas F Patterson, Carlos A Gomez, Vincent C Marconi
The Lancet. Respiratory Medicine. 2022-09-01
Press Mentions
IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
COVID-19 Treatment Trials Happening in HoustonMay 1st, 2020
Trial of Gilead’s Potential Coronavirus Treatment Running Ahead of ScheduleApril 27th, 2020- Join now to see all
Professional Memberships
- Member
- Infectious Diseases Society of AmericaFellow
- Harris County Medical SocietyMember
- Texas Medical AssociationMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
